Two questionnaires for Parkinson’s disease: are the PDQ-39 and PDQL equivalent?
- 430 Downloads
Although there is a wide range of specific health-related quality of life (HRQoL) measures for Parkinson’s disease (PD), their psychometric attributes have never been compared.
To compare the psychometric characteristics of the Parkinson’s Disease Questionnaire-39 items (PDQ-39) and Parkinson’s Disease Quality of Life Questionnaire (PDQL).
The PDQ-39 and PDQL were simultaneously applied to 187 PD patients. Additional assessments included Hoehn and Yahr staging, Schwab and England Scale (SES), Unified Parkinson’s Disease Rating Scale, Pfeiffer’s Short Portable Mental Status Questionnaire (SPMSQ) and Hospital Anxiety and Depression Scale (HADS). Criteria for acceptability, scaling assumptions, reliability, construct validity and precision were drawn up.
Both the PDQ-39 and PDQL proved very similar in the following aspects: acceptability (no floor or ceiling effect); scaling assumptions (79.5% and 80% respectively of item-total correlations fitted the standard); internal consistency (PDQ-39 domains, α = 0.43–0.93; PDQL domains, α = 0.70–0.88); stability (intraclass correlation coefficient = 0.76–0.90); and internal validity (PDQ-39, r = 0.09–0.70; PDQL, r = 0.52–0.71). Convergent validity between the two questionnaires was moderate to high (r = −0.91 for summary indices). Precision was higher for the PDQ-39 Summary Index, and predictors were the same for both measures (mood disorders and disability).
Although the psychometric properties tested are quite similar in both measures, mainly insofar as summary indices are concerned, differences in some attributes and structural content should nevertheless be considered when comparing both instruments.
KeywordsParkinson’s disease PDQ-39 PDQL Psychometric attributes Convergent validity
Activities of daily living
Hospital Anxiety and Depression Scale, Anxiety subscale
Hospital Anxiety and Depression Scale, Depression subscale
Health-related quality of life
Hoehn and Yahr scale
Intraclass correlation coefficient
Parkinson’s Disease Questionnaire-39 items
- PDQ-39 SI
Parkinson’s Disease Questionnaire-39 items, Summary Index
Parkinson’s Disease Quality of Life Questionnaire
- PDQL SI
Parkinson’s Disease Quality of Life Questionnaire, Summary Index
Standard error of measurement
Schwab and England Scale
Pfeiffer’s Short Portable Mental Status Questionnaire
Unified Parkinson’s Disease Rating Scale
This study was partially funded by a grant awarded by the Ramón y Cajal Research Fellowship Programme (Spanish Ministry of Education & Science) to Maria João Forjaz. C. Rodriguez-Blazquez helped with management of data and editorial work.
- 1.Shindler, J. S., Brown, R., Welburn, P., & Parkes, J. D. (1993). Measuring the quality of life of patients with Parkinson’s disease. In S. R. Walker & R. M. Rosser (Eds.), Quality of life assessment: Key issues in the 1990s (pp. 289–300). Dordrecht: Kluwer.Google Scholar
- 2.Martínez-Martín, P., & Koller, W. C. (Eds.) (1999). Quality of life in Parkinson’s disease. Barcelona: Masson SA.Google Scholar
- 3.Spilker, B. (Ed.) (1996). Quality of life and pharmacoeconomics in clinical trials (2nd ed.). Philadelphia: Lippincot-Raven Publishers.Google Scholar
- 12.Martinez-Martin, P., & Cubo E. Scales to measure Parkinsonism. In W. C. Koller & E. Melamed (Eds.), Parkinson’s disease and related disorders. Handbook of clinical neurology (vol. 83, 3rd series). Elsevier BV (in press).Google Scholar
- 15.Jenkinson, C., Fitzpatrick, R., Norquist, J., Findley, L., & Hughes, K. (2003). Cross-cultural evaluation of the Parkinson’s disease questionnaire: Tests of data quality, score reliability, response rate, scaling assumptions in the United States, Canada, Japan, Italy, and Spain. Journal of Clinical Epidemiology, 56, 843–847.PubMedCrossRefGoogle Scholar
- 18.Schwab, R. S., & England A. C. (1969). Projection technique for evaluating surgery in Parkinson’s disease. In F. J. Gillingham & I. M. L. Donaldson (Eds.), Third symposium on Parkinson’s disease (pp. 152–157). Edinburgh: E and S Livingstone.Google Scholar
- 19.Fahn, S., Elton, R. L., & Members of The UPDRS Development Committee (1987). Unified Parkinson’s disease rating scale. In S. Fahn, C. D. Marsden, M. Goldstein, & D. B. Calne (Eds.), Recent development in Parkinson’s disease (vol. 2, pp. 153–163). New Jersey: McMillan.Google Scholar
- 23.Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease (2003). The Unified Parkinson’s Disease Rating Scale (UPDRS): Status and recommendations. Movement Disorders, 18, 738–750.Google Scholar
- 27.Ware, J. E., Jr., Davies-Avery, A., & Donald, C. A. (1978). Conceptualization and measurement of health for adults in the health insurance study, Volume V: General health perceptions. Santa Monica, CA: The Rand Corporation.Google Scholar
- 31.Chassany, O., Sagnier, P., Marquis, P., Fullerton, S., & Aaronson, N. (2002). Patient-reported outcomes: The example of health-related quality of life—a European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Information Journal, 36, 209–238.Google Scholar
- 32.Fayers, P., & Machin, D. (2000). Quality of life: Assessment, analysis and interpretation (pp. 45–90). Chichester, United Kingdom: John Wiley & Sons. .Google Scholar